Pulmonary Division, Carmel Medical Center, Haifa 3436212, Israel.
Department of Internal Medicine B, Bnai Zion Medical Center, Haifa 3339419, Israel.
Int J Environ Res Public Health. 2022 May 1;19(9):5507. doi: 10.3390/ijerph19095507.
Inhaled ultrafine particle (UFP) content in exhaled breath condensate (EBC) was observed as an airway inflammatory marker and an indicator of exposure to particulate matter (PM). The exceptional decline in air pollution during the COVID-19 lockdown was an opportunity to evaluate the effect of environmental changes on UFP airway content. We collected EBC samples from 30 healthy subjects during the first lockdown due to COVID-19 in Israel (March-April 2020) and compared them to EBC samples retrieved during April-June 2016 from 25 other healthy subjects (controls) living in the same northern Israeli district. All participants underwent EBC collection and blood sampling. Ambient air pollutant levels were collected from the Israeli Ministry of Environmental Protection's online database. Data were acquired from the monitoring station closest to each subject's home address, and means were calculated for a duration of 1 month preceding EBC collection. UFP contents were measured in the EBC and blood samples by means of the NanoSight LM20 system. There was a dramatic reduction in NO, NO, SO, and O levels during lockdown compared to a similar period in 2016 (by 61%, 26%, 50%, and 45%, respectively). The specific NO levels were 8.3 ppb for the lockdown group and 11.2 ppb for the controls ( = 0.01). The lockdown group had higher UFP concentrations in EBC and lower UFP concentrations in serum compared to controls (0.58 × 10/mL and 4.3 × 10/mL vs. 0.43 × 10/mL and 6.7 × 10/mL, = 0.05 and = 0.03, respectively). In this observational study, reduced levels of air pollution during the COVID-19 lockdown were reflected in increased levels of UFP airway contents. The suggested mechanism is that low airway inflammation levels during lockdown resulted in a decreased UFP translocation to serum. Further studies are needed to confirm this hypothesis.
呼气冷凝物(EBC)中的吸入超细颗粒(UFP)含量被视为气道炎症标志物和颗粒物(PM)暴露的指标。由于 COVID-19 封锁,空气污染水平异常下降,这为评估环境变化对 UFP 气道含量的影响提供了机会。我们从以色列 COVID-19 首次封锁期间的 30 名健康受试者中收集了 EBC 样本(2020 年 3 月至 4 月),并将其与 2016 年 4 月至 6 月期间来自同一以色列北部地区的 25 名其他健康受试者(对照组)的 EBC 样本进行了比较。所有参与者都接受了 EBC 采集和血液采样。环境空气污染物水平从以色列环境保护部的在线数据库中收集。数据是从距离每个受试者家庭住址最近的监测站获取的,并计算了 EBC 采集前 1 个月的平均值。通过 NanoSight LM20 系统在 EBC 和血液样本中测量 UFP 含量。与 2016 年同期相比,封锁期间 NO、NO、SO 和 O 水平急剧下降(分别下降 61%、26%、50%和 45%)。封锁组的特定 NO 水平为 8.3 ppb,对照组为 11.2 ppb( = 0.01)。与对照组相比,封锁组的 EBC 中 UFP 浓度较高,血清中 UFP 浓度较低(0.58×10/mL 和 4.3×10/mL 与 0.43×10/mL 和 6.7×10/mL, = 0.05 和 = 0.03)。在这项观察性研究中,COVID-19 封锁期间空气污染水平的降低反映在 UFP 气道含量的增加上。提出的机制是,封锁期间气道炎症水平降低导致 UFP 向血清的转移减少。需要进一步的研究来证实这一假设。